LEGENDARY ACQUITY PERFORMANCE - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

LEGENDARY ACQUITY PERFORMANCE.
AT EVERY LEVEL FOR EVERY LAB.

In 2004, ACQUITY UPLC® gave future-focused labs the highest level of chromatographic performance the world had ever seen. Then came a dramatically greater demand for better results in less time. And UPLC® quickly went from leading-edge luxury to global necessity.

Today, Waters meets the ever-growing demand for higher levels of resolution and sensitivity with an ever-growing family of ACQUITY® Systems. That means for virtually any application, in every analytical lab, all over the world, there’s an ACQUITY System that’s right for you. To find the one that’s right for your lab, visit waters.com/ACQUITY.

Corporate Headquarters
Waters Corporation
34 Maple Street
Milford, MA 01757
T: 508-478-2000 or 1-800-252-4752
F: 508-872-1990
www.waters.com

European Headquarters
Waters S.A.S.
BP 608
78056 Saint-Quentin
En Yvelines Cedex, France
T: 33 1 30 48 72 00
F: 33 1 30 48 72 01
www.waters.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
FindPharma Custom Search

Click here